Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::
:::

2024年

  1. Chang LH, Chang TT, Chu CH, Huang CC, Lin LY*. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus. Clin Chim Acta 2024;558:117880. (IF: 3.2)
  2. Chang TT*, Li YZ, Mo HW, Chen C, Lin LY, Chang CC, Chen JW. Inhibition of CCL7 improves endothelial dysfunction and vasculopathy in mouse models of diabetes mellitus. Sci Transl Med 2024;16(763):eadn1507. (IF: 15.8)
  3. Chang TT*, Lin LY, Chen C, Chen JW*. CCL4 contributes to aging related angiogenic insufficiency through activating oxidative stress and endothelial inflammation. Angiogenesis 2024;27(3):475-499. (IF: 9.2)
  4. Chen C, Lin LY, Wu YW, Chen JW, Chang TT*. CXCL5 inhibition improves kidney function by protecting renal tubular epithelial cells in diabetic kidney disease. Clin Immunol 2024;268:110369. (IF: 4.5)
  5. Chen CE, Guo JY, Chou RH*, Wu CH, Kuo CS, Wei JH, Huang PH*. Circulating corin concentration is associated with risk of mortality and acute kidney injury in critically ill patients. Sci Rep 2024;14(1):19848. (IF: 3.8)
  6. Chen KL, Chou RH*, Chang CC, Kuo CS, Wei JH, Huang PH*, Lin SJ. The high-density lipoprotein cholesterol (HDL-C)-concentration-dependent association between anti-inflammatory capacity and sepsis: A single-center cross-sectional study. PLoS One 2024;19(4):e0296863. (IF: 2.9)
  7. Chen YY, Huang SC, Pan CT, Peng KY, Lin LY, Chan CK*, Shun CT. The predictors of long-term outcomes after targeted therapy for primary Aldosteronism. J Formos Med Assoc 2024;123():S135-S140. (IF: 2.6)
  8. Cheng WY, Chang LH, Chen HS*. The effect of statin treatment on glucose homeostasis in prediabetic individuals: A prospective randomized controlled trial. J Chin Med Assoc 2024;87(7):664-669. (IF: 1.9)
  9. Cheng YF, Wang CC*, Tsai PS, Lin DC, Huang WH. Langerhans cell histiocytosis of the thyroid mimicking thyroiditis in a boy: a case report and literature review. BMC Pediatr 2024;24(1):66. (IF: 2.0)
  10. Cheng YS, Lin CP, Chen LYA, Hwang WR, Lin YC, Chen YC*. Short-Term Effects of an eHealth Care Experiential Learning Program Among Patients With Type 2 Diabetes: Randomized Controlled Trial. J Med Internet Res 2024;26:e53509. (IF: 5.8)
  11. Chiu LT, Lin YL, Wang CH, Hwu CM, Liou HH*, Hsu BG*. Electrochemical Skin Conductance by Sudoscan in Non-Dialysis Chronic Kidney Disease Patients. J Clin Med 2024;13(1):187. (IF: 3.0)
  12. Hawkes G*, Beaumont RN, Li ZL, Mandla R, Li XH, Albert CM, Arnett DK, Ashley-Koch AE, Ashrani AA, Barnes KC, Boerwinkle E, Brody JA, Carson AP, Chami N, Chen YDI, Chung MK, Curran JE, Darbar D, Ellinor PT, Fornage M, Gordeuk VR, Guo XQ, He J, Hwu CM, Kalyani RR, Kaplan R, Kardia SLR, Kooperberg C, Loos RJF, Lubitz SA, Minster RL, Naseri T, Viali S, Mitchell BD, Murabito JM, Palmer ND, Psaty BM, Redline S, Shoemaker MB, Silverman EK, Telen MJ, Weiss ST, Yanek LR, Zhou HF, Liu CT, North KE, Justice AE, Locke JM, Owens N, Murray A, Patel K, Frayling TM, Wright CF, Wood AR, Lin XH, Manning A, Weedon MN*. Whole-genome sequencing in 333,100 individuals reveals rare non-coding single variant and aggregate associations with height. Nat Commun 2024;15(1):8549. (IF: 14.7)
  13. Hsiao YC, Lee TL, Lin FJ, Hsuan CF, Yeh CF, Chang WT, Kao HL, Jeng JS, Wu YW, Hsieh IC, Fang CC, Wang KY, Chang KC, Lin TH, Sheu WHH, Li YH, Yin WH, Yeh H, Chen JW, Wu CC*. A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study. Biomed J 2024;47(3):100653. (IF: 4.1)
  14. Hu YS, Wu CA, Lin DC, Lin PW, Lee HJ, Lin LY, Lin CJ*. Applying ONCO-RADS to whole-body MRI cancer screening in a retrospective cohort of asymptomatic individuals. Cancer Imaging 2024;24(1):22. (IF: 3.5)
  15. Huang CC, Yeh HY, Lin R, Liao TL, Shen HC, Yang YY*, Lin HC. Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A<sub>2A</sub>R improves hepatic and cardiac dysfunction of NASH mice. Am J Physiol-Gastroint Liver Physiol 2024;326(4):G385-G397. (IF: 3.9)
  16. Huang CJ, Li JZ, Hwu CM, Chen HS, Yeh CC, Wang FF*, Yang CC*. Determination of the Elemental Iodine in Human Breast Milk by Inductively Coupled Plasma mass Spectrometry. Biol Trace Elem Res 2024;202(4):1517-1523. (IF: 3.4)
  17. Huang CW, Tu KH, Fan KC, Tsai CH, Wang WT, Wang SY, Wu CY, Hu YH, Huang SH, Liu HW, Tseng FY, Wu WC*, Chang CC, Lin YH, Wu VC, Hwu CM. The role of confirmatory tests in the diagnosis of primary aldosteronism. J Formos Med Assoc 2024;123():S104-S113. (IF: 2.6)
  18. Huang JF, Chang TJ, Yeh ML, Shen FC, Tai CM, Chen JF, Huang YH, Hsu CY, Cheng PN, Lin CL, Hung CH, Chen CC, Lee MH, Lee CC, Lin CW, Liu SC, Yang H, Chien RN, Kuo CS, Peng CY, Chang ML, Huang CF, Yang YS, Yang HC, Lin HC, Ou HY, Liu CJ, Tseng CH, Kao JH, Chuang WL, Huang CN, Chen PJ, Wang CY*, Yu ML*. Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus. Hepatol Commun 2024;8(11):e0571. (IF: 5.6)
  19. Ko FS, Yeh YK, Yen FS*, Hwu CM*. Deciphering the causal tapestry between cardiorespiratory fitness and type 2 diabetes mellitus. J Diabetes Investig 2024;15(4):426-428. (IF: 3.1)
  20. Kuo CS, Chen HS*. β-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy. Diabetes Res Clin Pract 2024;215:111814. (IF: 6.1)
  21. Kuo CS, Kuo NR, Yeh YK, Lee YJ, Chuang LM, Chen HF, Chen CC, Lee CC, Hsu CC, Li HY, Ou HY*, Hwu CM*. Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study. Lipids Health Dis 2024;23(1):24. (IF: 3.9)
  22. Lai HF, Hang JF, Kuo PC, Kuo CS, Yao SF, Chen JY*, Lee CH. <i>BRAF V600E</i> Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma. Ann Surg Oncol 2024;31(5):3495-3501. (IF: 3.4)
  23. Lee CC, Ko FS, Yen FS*, Hwu CM*. LX9211 a rising star for relieving of diabetic peripheral neuropathic pain. J Diabetes Investig 2024;():doi: 10.1111/jdi.14342. (IF: 3.1) (Epub ahead of print不列入)
  24. Lee PS, Chen JY, Pan LH, Hwu CM, Hang JF, Kuo CS*. Unveiling a rare BRAF mutation in minimally invasive follicular thyroid carcinoma: A case report. Medicine (Baltimore) 2024;103(34):e39364. (IF: 1.4)
  25. Lin LY*, Chang TT, Leu HB, Huang CC, Wu TC, Chou RH, Huang PH, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh H, Chang KC, Wang JH, Wu CC, Chen JW*. Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease. Clin Res Cardiol 2024;():doi: 10.1007/s00392-024-02458-7. (IF: 3.8) (Epub ahead of print不列入)
  26. Lin YH, Chang HT*, Wang YF, Fuh JL, Wang SJ, Chen HS, Li SR, Lin MH, Chen TJ, Hwang SJ. The association of the comorbidity status of metabolic syndrome and cognitive dysfunction with health-related quality of life. Qual Life Res 2024;33(12):3421-3433. (IF: 3.3)
  27. Malik RA*, Hwu CM, Jammah AA, Arteaga-Diaz JM, Djaballah K, Pilorget V, Alvarez A, Vera C, Vikulova O. Real-world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international multicentre 12-month prospective observational study. Diabetes Obes Metab 2024;26(7):2811-2819. (IF: 5.4)
  28. Pan LH, Chen YY, Pan CT, Hsu CY, Tseng CS, Yen IW, Chan CK, Lin LY*. Follow-up care and assessment of comorbidities and complications in patients with primary aldosteronism: The clinical practice guideline of the Taiwan Society of aldosteronism. J Formos Med Assoc 2024;123():S141-S152. (IF: 2.6)
  29. Shen FC, Chu CH, Chen JF, Kuo CS, Hsu CY, Lin CH, Sheen YJ, Su SC, Tien KJ, Lu CH, Lee CC, Yang YS, Tu ST, Chen PT, Chen CC, Chien MN, Li HY, Sheu WHH, Huang CN*, Wang CY*, Ou HY*. Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators. J Diabetes Investig 2024;15(8):1151-1160. (IF: 3.1)
  30. Shen HC, Pan MH, Huang CJ, Yeh HY, Yang H, Lin YH, Huang CC, Lee KC, Yang YY*, Hou MC. Multiple genetic polymorphisms are associated with the risk of metabolic syndrome fatty liver and airflow limitation: A Taiwan Biobank study. Gene 2024;927:148660. (IF: 2.6)
  31. Sheu WHH*. Birthweight and risk of diabetes in later life. J Diabetes Investig 2024;15(5):557-558. (IF: 3.1)
  32. Smith JL, Tcheandjieu C, Dikilitas O, Iyer K, Miyazawa K, Hilliard A, Lynch J, Rotter JI, Chen YDI, Sheu WHH, Chang KM, Kanoni S, Tsao PS, Ito K, Kosel M, Clarke SL, Schaid DJ, Assimes TL, Kullo IJ*. Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization. Circ-Genom Precis Med 2024;17(3):e004272. (IF: 6.0)
  33. Su GY, Yeh CC, Yang SJ, Yang CC, Hwu CM, Wang FF, Huang CJ*. Assessment of iodine nutritional status and gestational thyroid function reference ranges during the first trimester of pregnancy in Taiwan. J Chin Med Assoc 2024;87(6):590-596. (IF: 1.9)
  34. Suzuki K, Hatzikotoulas K*, Southam L, Taylor HJ, Yin XY, Lorenz KM, Mandla R, Huerta-Chagoya A, Melloni GEM, Kanoni S, Rayner NW, Bocher O, Arruda AL, Sonehara K, Namba S, Lee SSK, Preuss MH, Petty LE, Schroeder P, Vanderwerff B, Kals M, Bragg F, Lin K, Guo XQ, Zhang WH, Yao J, Kim YJ, Graff M, Takeuchi F, Nano J, Lamri A, Nakatochi M, Moon S, Scott RA, Cook JP, Lee JJ, Pan I, Taliun D, Parra EJ, Chai JF, Bielak LF, Tabara Y, Hai Y, Thorleifsson G, Grarup N, Sofer T, Wuttke M, Sarnowski C, Gieger C, Nousome D, Trompet S, Kwak SH, Long J, Sun M, Tong L, Chen WM, Nongmaithem SS, Noordam R, Lim VJY, Tam CHT, Joo YY, Chen CH, Raffield LM, Prins BP, Nicolas A, Yanek LR, Chen GJ, Brody JA, Kabagambe E, An P, Xiang AH, Choi HS, Cade BE, Tan JY, Broadaway KA, Williamson A, Kamali Z, Cui JR, Thangam M, Adair LS, Adeyemo A, Aguilar-Salinas CA, Ahluwalia TS, Anand SS, Bertoni A, Bork-Jensen J, Brandslund I, Buchanan TA, Burant CF, Butterworth AS, Canouil M, Chan JCN, Chang LC, Chee ML, Chen J, Chen SH, Chen YT, Chen ZM, Chuang LM, Cushman M, Danesh J, Das SK, de Silva HJ, Dedoussis G, Dimitrov L, Doumatey AP, Du SF, Duan Q, Eckardt KU, Emery LS, Evans DS, Evans MK, Fischer K, Floyd JS, Ford I, Franco OH, Frayling TM, Freedman BI, Genter P, Gerstein HC, Giedraitis V, Gonzalez-Villalpando C, Gonzalez-Villalpando ME, Gordon-Larsen P, Gross M, Guare LA, Hackinger S, Hakaste L, Han S, Hattersley AT, Herder C, Horikoshi M, Howard AG, Hsueh W, Huang MN, Huang W, Hung YJ, Hwang MY, Hwu CM, Ichihara S, Ikram MA, Ingelsson M, Islam MT, Isono M, Jang HM, Jasmine F, Jiang GZ, Jonas JB, Jorgensen T, Kamanu FK, Kandeel FR, Kasturiratne A, Katsuya T, Kaur V, Kawaguchi T, Keaton JM, Kho AN, Khor CC, Kibriya MG, Kim DH, Kronenberg F, Kuusisto J, Lall K, Lange LA, Lee KM, Lee MS, Lee NR, Leong A, Li LM, Li Y, Li-Gao RF, Ligthart S, Lindgren CM, Linneberg A, Liu CT, Liu JJ, Locke AE, Louie T, Luan JA, Luk AO, Luo X, Lv J, Lynch JA, Lyssenko V, Maeda S, Mamakou V, Mansuri SR, Matsuda K, Meitinger T, Melander O, Metspalu A, Mo H, Morris AD*, Moura FA, Nadler JL, Nalls MA, Nayak U, Ntalla I, Okada Y, Orozco L, Patel SR, Patil S, Pei P, Pereira MA, Peters A, Pirie FJ, Polikowsky HG, Porneala B, Prasad G, Rasmussen-Torvik LJ, Reiner AP, Roden M, Rohde R, Roll K, Sabanayagam C, Sandow K, Sankareswaran A, Sattar N, Schonherr S, Shahriar M, Shen BT, Shi JX, Shin DM, Shojima N, Smith JA, So WY, Stancakova A, Steinthorsdottir V, Stilp AM, Strauch K, Taylor KD, Thorand B, Thorsteinsdottir U, Tomlinson B, Tran TC, Tsai FJ, Tuomilehto J, Tusie-Luna T, Udler MS, Valladares-Salgado A, van Dam RM, van Klinken JB, Varma R, Wacher-Rodarte N, Wheeler E, Wickremasinghe AR, van Dijk KW, Witte DR, Yajnik CS, Yamamoto K, Yamamoto K, Yoon K, Yu CQ, Yuan JM, Yusuf S, Zawistowski M, Zhang L, Zheng W, Raffel LJ, Igase M, Ipp E, Redline S, Cho YS, Lind L, Province MA, Fornage M, Hanis CL, Ingelsson E, Zonderman AB, Psaty BM, Wang YX, Rotimi CN, Becker DM, Matsuda F, Liu YM, Yokota M, Kardia SLR, Peyser PA, Pankow JS, Engert JC, Bonnefond A, Froguel P, Wilson JG, Sheu WHH, Wu JY, Hayes MG, Ma RCW, Wong TY, Mook-Kanamori DO, Tuomi T, Chandak GR, Collins FS, Bharadwaj D, Pare G, Sale MM, Ahsan H, Motala AA, Shu XO, Park KS, Jukema JW, Cruz M, Chen YDI, Rich SS, McKean-Cowdin R, Grallert H, Cheng CY, Ghanbari M, Tai ES, Dupuis J, Kato N, Laakso M, Kottgen A, Koh WP, Bowden DW, Palmer CNA, Kooner JS, Kooperberg C, Liu S, North KE, Saleheen D, Hansen T, Pedersen O, Wareham NJ, Lee J, Kim BJ, Millwood IY, Walters RG, Stefansson K, Ahlqvist E, Goodarzi MO, Mohlke KL, Langenberg C, Haiman CA, Loos RJF, Florez JC, Rader DJ, Ritchie MD, Zollner S, Magi R, Marston NA, Ruff CT, van Heel DA, Finer S, Denny JC, Yamauchi T, Kadowaki T, Chambers JC, Ng MCY, Sim XL, Below JE, Tsao PS, Chang KM, McCarthy MI, Meigs JB, Mahajan A, Spracklen CN, Mercader JM, Boehnke M, Rotter JI, Vujkovic M, Voight BF, Morris AP, Zeggini E. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature 2024;627(8003):347-357. (IF: 50.5)
  35. Wei SY, Liu YP, Lin DC, Tsai PS*. Klippel-Trenaunay syndrome with profound abdominal lymphatic-venous malformation in a three-day-old newborn: a case report and literature review. Front Pediatr 2024;12:1326909. (IF: 2.1)
  36. Yang JH, Lin WL, Chen WS, Jiang JK, Yang SH, Wang HS, Chang SC, Lan YT, Lin CC, Lin HH, Huang SC, Cheng HH, Yang YW, Lin YZ, Hsu HM, Lin CJ, Teng HW*. The survival outcome differs between left-sided colon cancer and middle/low rectal cancer after colorectal hepatic metastasectomy. J Gastrointest Surg 2024;28(8):1250-1258. (IF: 2.2)
  37. Yang YH, Chang YL, Lee BC, Lu CC, Wang WT, Hu YH, Liu HW, Lin YH, Chang CC*, Wu WC, Tseng FY, Lin YH, Wu VC, Hwu CM. Strategies for subtyping primary aldosteronism. J Formos Med Assoc 2024;123():S114-S124. (IF: 2.6)
  38. Yeh YK, Lin KH, Sheu WHH, Lo SH, Yeh YP, Huang CN, Hwu CM*, Lu CH*. Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry. BMC Nephrol 2024;25(1):133. (IF: 2.2)
  39. Yeh YK, Yen FS, Wei JCC, Hu KC, Yu TS, Hsu CC*, Hwu CM*. Metformin and the risks of cellulitis foot infections and amputation in patients with type 2 diabetes. J Chin Med Assoc 2024;87(4):384-392. (IF: 1.9)
  40. Yen FS, Hou MC, Wei JCC, Shih YH, Hsu CY, Hsu CC*, Hwu CM*. Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes. Clin Gastroenterol Hepatol 2024;22(6):1255-1264. (IF: 11.6)
  41. Yen FS, Hou MC, Wei JCC, Shih YH, Hwu CM*, Hsu CC*. Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes. BMC Med 2024;22(1):8. (IF: 7.1)
  42. Yen FS, Hwu CM, Liu JS, Wu YL, Chong K, Hsu CC*. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease. Ann Intern Med 2024;177(6):693-700. (IF: 19.6)
  43. Yen FS, Wang SI, Hsu CC, Hwu CM*, Wei JCC*. Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus Erythematosus. JAMA Netw Open 2024;7(6):e2416578. (IF: 10.5)
  44. Yen FS, Wei JCC, Wu YL, Lo YR, Chen CM, Hwu CM, Hsu CC*. Impact of family income on the development of gestational diabetes mellitus and the associated birth outcomes: A nationwide study. J Diabetes Investig 2024;16(1):51-59. (IF: 3.1)
  45. Yen FS*, Hwu CM, Hsu CC. A Reply. Clin Gastroenterol Hepatol 2024;22(4):902-903. (IF: 11.6)
  46. Yen YH, Yen FS, Ko FS, Wei JCC, Huang YH, Yu TS, Hwu CM*, Hsu CC*. Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan. Diabetes Obes Metab 2024;26(11):5399-5407. (IF: 5.4)
  47. Ying TH, Huang CJ, Hsieh CJ, Wu PJ, Yeh CC, Hung PK, Chang WH, Wu MH, Hung H, Chang JW, Wang CT, Arcega RD, Mahmudiono T, Lee CC, Chen HL*. Potential Factors Associated with the Blood Metal Concentrations of Reproductive-Age Women in Taiwan. Expo Health 2024;16(1):71-86. (IF: 4.6)
  48. Ying TH, Huang CJ, Hsieh CJ, Wu PJ, Yeh CC, Hung PK, Chang WH, Wu MH, Hung H, Chang JW, Wang CT, Arcega RD, Mahmudiono T, Lee CC, Chen HL*. Potential Factors Associated with the Blood Metal Concentrations of Reproductive-Age Women in Taiwan (Mar 10.1007/s12403-023-00541-4 2023). Expo Health 2024;16(2):617-617. (IF: 4.6)
  49. Ying TH, Huang CJ, Hsieh CJ, Wu PJ, Yeh CC, Hung PK, Chang WH, Wu MH, Hung H, Chang JW, Wang CT, Arcega RD, Mahmudiono T, Lee CC, Chen HL*. Potential Factors Associated with the Blood Metal Concentrations of Reproductive-Age Women in Taiwan (vol 16 pg 71 2024). Expo Health 2024;16(5):1291-1291. (IF: 4.6)

最後更新:

回到最上